232 related articles for article (PubMed ID: 35121988)
21. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
[TBL] [Abstract][Full Text] [Related]
22. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
[TBL] [Abstract][Full Text] [Related]
23. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.
Zhao Y; Kong X; Li X; Yan S; Yuan C; Hu W; Yang Q
PLoS One; 2011; 6(12):e29363. PubMed ID: 22195048
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.
Meng X; Zhu D; Yang S; Wang X; Xiong Z; Zhang Y; Brachova P; Leslie KK
J Biol Chem; 2012 Feb; 287(7):4485-91. PubMed ID: 22199357
[TBL] [Abstract][Full Text] [Related]
25. SND1 expression in breast cancer tumors is associated with poor prognosis.
Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
[TBL] [Abstract][Full Text] [Related]
26. Mechanism for Bioactive Nanomaterial circ0024831 Regulation of Staphylococcal Nuclease Domain Containing 1 via RNA Methylation Recognition in Osteosarcoma.
Zheng H; Wang J; Zhang W; He B; Wang Y; Zhang X; Mao H; Fan L
J Biomed Nanotechnol; 2022 Feb; 18(2):453-462. PubMed ID: 35484754
[TBL] [Abstract][Full Text] [Related]
27. SND1, a novel co-activator of HIF1α, promotes tumor initiation in PyMT-induced breast tumor.
Hu L; Zeng Y; Xin L; Yang J
FEBS J; 2023 Dec; 290(24):5759-5772. PubMed ID: 37622244
[TBL] [Abstract][Full Text] [Related]
28. Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer.
Makki Almansour N
Saudi Pharm J; 2023 Oct; 31(10):101751. PubMed ID: 37693734
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression.
Lai TH; Ahmed M; Hwang JS; Zada S; Pham TM; Elashkar O; Kim DR
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802672
[TBL] [Abstract][Full Text] [Related]
30. SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis.
Yu L; Liu X; Cui K; Di Y; Xin L; Sun X; Zhang W; Yang X; Wei M; Yao Z; Yang J
Cancer Res; 2015 Apr; 75(7):1275-86. PubMed ID: 25596283
[TBL] [Abstract][Full Text] [Related]
31. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
[TBL] [Abstract][Full Text] [Related]
32. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
[TBL] [Abstract][Full Text] [Related]
33. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Hu G; Chong RA; Yang Q; Wei Y; Blanco MA; Li F; Reiss M; Au JL; Haffty BG; Kang Y
Cancer Cell; 2009 Jan; 15(1):9-20. PubMed ID: 19111877
[TBL] [Abstract][Full Text] [Related]
34. Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression.
Chen H; Zhan M; Zhang Y; Liu J; Wang R; An Y; Gao Z; Jiang L; Xing Y; Kang Y; Li Z; Yin F
JACS Au; 2024 Jan; 4(1):139-149. PubMed ID: 38274259
[TBL] [Abstract][Full Text] [Related]
35. Tipping the balance: MTDH-SND1 curbs oncogene-induced apoptosis and promotes tumorigenesis.
Kannan N; Eaves CJ
Cell Stem Cell; 2014 Aug; 15(2):118-20. PubMed ID: 25105576
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance mediated by AEG-1/MTDH/LYRIC.
Meng X; Thiel KW; Leslie KK
Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
Kuruma H; Kamata Y; Takahashi H; Igarashi K; Kimura T; Miki K; Miki J; Sasaki H; Hayashi N; Egawa S
Am J Pathol; 2009 Jun; 174(6):2044-50. PubMed ID: 19435788
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
[TBL] [Abstract][Full Text] [Related]
39. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.
Cui X; Zhang X; Liu M; Zhao C; Zhang N; Ren Y; Su C; Zhang W; Sun X; He J; Gao X; Yang J
Genomics; 2020 Nov; 112(6):3958-3967. PubMed ID: 32645525
[TBL] [Abstract][Full Text] [Related]
40. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.
Santhekadur PK; Das SK; Gredler R; Chen D; Srivastava J; Robertson C; Baldwin AS; Fisher PB; Sarkar D
J Biol Chem; 2012 Apr; 287(17):13952-8. PubMed ID: 22396537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
